Perpetua Resources Secures 29 Billion US Loan for Idaho Critical Minerals Project Chennai PortMaduravoyal Elevated Corridor Targets November 2027 Completion Attacks on Preah Vihear Temple May Undermine Global Heritage Preservation Efforts HELOC Rates Hold Near 2026 Low as Truist Named Top Lender for Flexible Features Mortgage Rates Edge Up to 653 Adding Pressure on Spring Homebuyers Mortgage Rates Show Mixed Movements as 30Year Fixed Declines and 15Year Rises Interlink Electronics Q3 2025 Earnings EPS Surprise Despite Narrow Loss Cartesian Therapeutics Inc RNAC Q1 2026 Earnings ClinicalStage Biotech Reports WiderThanExpected Loss Stock Ticks Higher CNXC Q1 2026 Earnings EPS Misses Estimates as Revenue Growth Remains Uncertain CQP Q1 2026 Earnings Significant EPS Miss as Distributable Cash Flow Declines GNLX Q1 2026 Earnings EPS Miss Amid PreRevenue Development Stage Stock Edges Higher ALNT Q1 2026 Earnings EPS Falls Short of Estimates Stock Holds Steady Gyrodyne LLC GYRO Holds Steady at 711 as Support and Resistance Levels Define Trading Range Crane Harbor Acquisition Corp Rights CHACR Surges 1728 as Rights Trading Gains Momentum BOK Financial BOKF Climbs 13 as Support Holds Firm Trailblazer Merger Corporation I TBMC Plunges Over 33 as Support Levels Are Tested Lulus Fashion Lounge LVLU Dips Nearly 4 as Stock Approaches Key Support Levels First National Corporation FXNC Q1 2026 Earnings EPS Misses Estimates Amid Modest Stock Gain Chemours Q1 2026 Earnings Strong EPS Surprise Despite Ongoing Headwinds DYAI Q1 2026 Earnings EPS Misses Mark as PreRevenue Biotech Maintains Pipeline Focus CWT Q1 2026 Earnings Earnings Miss Amidst Operational Challenges Stock Still Rises WDS Q4 2025 Earnings EPS Surges 338 Above Estimates on Strong Operational Performance APGE Q1 2026 Earnings Apogee Therapeutics Narrows Loss Per Share Stock Slips Slightly Michael Saylor Tokenization Could Create a Free Market in Credit and Yield Challenging Traditional Banking Arcturus Therapeutics Holdings Inc ARCT Q1 2026 Earnings EPS Beat Narrowed Net Loss No Revenue Reported PROCEPT BioRobotics PRCT Holds Steady Near Support Amid Low Volatility